img

Global and India Clinical Whole Exome Sequencing (WES) Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and India Clinical Whole Exome Sequencing (WES) Market Report & Forecast 2024-2034

Clinical Whole Exome Sequencing (WES) is a comprehensive genetic test that identifies changes in a patient's DNA that cause or are related to their medical problems. By focusing on the entire protein-coding region of the genome (the exome), it provides the coverage needed to diagnose patients quickly and reliably.
The global Clinical Whole Exome Sequencing (WES) revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In India, the Clinical Whole Exome Sequencing (WES) revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Clinical Whole Exome Sequencing (WES) include CentoXome, Mayo Clinic Laboratories, Baylor Genetics, Blueprint Genetics, GeneDx, CD Genomics, Illumina, Thermo Fisher and Labassure, etc. The global five biggest players hold a share of % in 2022.
This report focuses on global and India Clinical Whole Exome Sequencing (WES) market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Clinical Whole Exome Sequencing (WES) will continue to grow rapidly in the future.
Global Clinical Whole Exome Sequencing (WES) Scope and Market Size
Clinical Whole Exome Sequencing (WES) market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Clinical Whole Exome Sequencing (WES) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the Clinical Whole Exome Sequencing (WES) market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.



By Company


CentoXome
Mayo Clinic Laboratories
Baylor Genetics
Blueprint Genetics
GeneDx
CD Genomics
Illumina
Thermo Fisher
Labassure
Yale Medicine
Genosalut
Caris Life Sciences
InterGenetics
Genomics and Pathology Services (GPS)
3billion
Broad Genomic
Roche
Novogene
BGI Genomics
Shanghai Jingzhou Genomics
Shihe Gene Biotechnology
JUNO Genomics
Segment by Type
Array-Based Exome Enrichment
Enrichment of the Exome in Solution using Biotinylated Probes

Segment by Application


Rare Genetic Disease
Genetic Testing Unsuccessful
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Clinical Whole Exome Sequencing (WES) definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Clinical Whole Exome Sequencing (WES) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Clinical Whole Exome Sequencing (WES) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Whole Exome Sequencing (WES) revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Clinical Whole Exome Sequencing (WES) Product Introduction
1.2 Global Clinical Whole Exome Sequencing (WES) Outlook 2018 VS 2022 VS 2033
1.2.1 Global Clinical Whole Exome Sequencing (WES) Market Size for the Year 2018-2033
1.2.2 India Clinical Whole Exome Sequencing (WES) Market Size for the Year 2018-2033
1.3 Clinical Whole Exome Sequencing (WES) Market Size, India VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of India Clinical Whole Exome Sequencing (WES) in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Clinical Whole Exome Sequencing (WES) Market Size, India VS Global, 2018 VS 2022 VS 2033
1.4 Clinical Whole Exome Sequencing (WES) Market Dynamics
1.4.1 Clinical Whole Exome Sequencing (WES) Industry Trends
1.4.2 Clinical Whole Exome Sequencing (WES) Market Drivers
1.4.3 Clinical Whole Exome Sequencing (WES) Market Challenges
1.4.4 Clinical Whole Exome Sequencing (WES) Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Clinical Whole Exome Sequencing (WES) by Type
2.1 Clinical Whole Exome Sequencing (WES) Market Segment by Type
2.1.1 Array-Based Exome Enrichment
2.1.2 Enrichment of the Exome in Solution using Biotinylated Probes
2.2 Global Clinical Whole Exome Sequencing (WES) Market Size by Type (2018, 2022 & 2033)
2.3 Global Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2033)
2.4 India Clinical Whole Exome Sequencing (WES) Market Size by Type (2018, 2022 & 2033)
2.5 India Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2033)
3 Clinical Whole Exome Sequencing (WES) by Application
3.1 Clinical Whole Exome Sequencing (WES) Market Segment by Application
3.1.1 Rare Genetic Disease
3.1.2 Genetic Testing Unsuccessful
3.1.3 Others
3.2 Global Clinical Whole Exome Sequencing (WES) Market Size by Application (2018, 2022 & 2033)
3.3 Global Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2033)
3.4 India Clinical Whole Exome Sequencing (WES) Market Size by Application (2018, 2022 & 2033)
3.5 India Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2033)
4 Global Clinical Whole Exome Sequencing (WES) Competitor Landscape by Company
4.1 Global Clinical Whole Exome Sequencing (WES) Market Size by Company
4.1.1 Global Key Companies of Clinical Whole Exome Sequencing (WES), Ranked by Revenue (2022)
4.1.2 Global Clinical Whole Exome Sequencing (WES) Revenue by Player (2018-2023)
4.2 Global Clinical Whole Exome Sequencing (WES) Concentration Ratio (CR)
4.2.1 Clinical Whole Exome Sequencing (WES) Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Clinical Whole Exome Sequencing (WES) in 2022
4.2.3 Global Clinical Whole Exome Sequencing (WES) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Clinical Whole Exome Sequencing (WES) Head office and Area Served
4.4 Global Key Players of Clinical Whole Exome Sequencing (WES), Product and Application
4.5 Global Key Players of Clinical Whole Exome Sequencing (WES), Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Clinical Whole Exome Sequencing (WES) Market Size by Company
4.7.1 Key Players of Clinical Whole Exome Sequencing (WES) in India, Ranked by Revenue (2022)
4.7.2 India Clinical Whole Exome Sequencing (WES) Revenue by Players (2021, 2022 & 2023)
5 Global Clinical Whole Exome Sequencing (WES) Market Size by Region
5.1 Global Clinical Whole Exome Sequencing (WES) Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Clinical Whole Exome Sequencing (WES) Market Size by Region (2018-2033)
5.2.1 Global Clinical Whole Exome Sequencing (WES) Market Size by Region: 2018-2023
5.2.2 Global Clinical Whole Exome Sequencing (WES) Market Size by Region (2024-2033)
6 Americas
6.1 Americas Clinical Whole Exome Sequencing (WES) Market Size YoY Growth 2018-2033
6.2 Americas Clinical Whole Exome Sequencing (WES) Market Size by Type
6.2.1 Americas Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023)
6.2.2 Americas Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033)
6.2.3 Americas Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
6.3 Americas Clinical Whole Exome Sequencing (WES) Market Size by Application
6.3.1 Americas Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023)
6.3.2 Americas Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033)
6.3.3 Americas Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
6.4 Americas Clinical Whole Exome Sequencing (WES) Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Clinical Whole Exome Sequencing (WES) Market Size YoY Growth 2018-2033
7.2 EMEA Clinical Whole Exome Sequencing (WES) Market Size by Type
7.2.1 EMEA Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023)
7.2.2 EMEA Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033)
7.2.3 EMEA Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
7.3 EMEA Clinical Whole Exome Sequencing (WES) Market Size by Application
7.3.1 EMEA Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023)
7.3.2 EMEA Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033)
7.3.3 EMEA Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
7.4 EMEA Clinical Whole Exome Sequencing (WES) Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Clinical Whole Exome Sequencing (WES) Market Size YoY Growth 2018-2033
8.2 China Clinical Whole Exome Sequencing (WES) Market Size by Type
8.2.1 China Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023)
8.2.2 China Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033)
8.2.3 China Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
8.3 China Clinical Whole Exome Sequencing (WES) Market Size by Application
8.3.1 China Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023)
8.3.2 China Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033)
8.3.3 China Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Clinical Whole Exome Sequencing (WES) Market Size YoY Growth 2018-2033
9.2 APAC Clinical Whole Exome Sequencing (WES) Market Size by Type
9.2.1 APAC Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023)
9.2.2 APAC Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033)
9.2.3 APAC Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
9.3 APAC Clinical Whole Exome Sequencing (WES) Market Size by Application
9.3.1 APAC Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023)
9.3.2 APAC Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033)
9.3.3 APAC Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
9.4 APAC Clinical Whole Exome Sequencing (WES) Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 CentoXome
10.1.1 CentoXome Company Details
10.1.2 CentoXome Business Overview
10.1.3 CentoXome Clinical Whole Exome Sequencing (WES) Introduction
10.1.4 CentoXome Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.1.5 CentoXome Recent Development
10.2 Mayo Clinic Laboratories
10.2.1 Mayo Clinic Laboratories Company Details
10.2.2 Mayo Clinic Laboratories Business Overview
10.2.3 Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Introduction
10.2.4 Mayo Clinic Laboratories Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.2.5 Mayo Clinic Laboratories Recent Development
10.3 Baylor Genetics
10.3.1 Baylor Genetics Company Details
10.3.2 Baylor Genetics Business Overview
10.3.3 Baylor Genetics Clinical Whole Exome Sequencing (WES) Introduction
10.3.4 Baylor Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.3.5 Baylor Genetics Recent Development
10.4 Blueprint Genetics
10.4.1 Blueprint Genetics Company Details
10.4.2 Blueprint Genetics Business Overview
10.4.3 Blueprint Genetics Clinical Whole Exome Sequencing (WES) Introduction
10.4.4 Blueprint Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.4.5 Blueprint Genetics Recent Development
10.5 GeneDx
10.5.1 GeneDx Company Details
10.5.2 GeneDx Business Overview
10.5.3 GeneDx Clinical Whole Exome Sequencing (WES) Introduction
10.5.4 GeneDx Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.5.5 GeneDx Recent Development
10.6 CD Genomics
10.6.1 CD Genomics Company Details
10.6.2 CD Genomics Business Overview
10.6.3 CD Genomics Clinical Whole Exome Sequencing (WES) Introduction
10.6.4 CD Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.6.5 CD Genomics Recent Development
10.7 Illumina
10.7.1 Illumina Company Details
10.7.2 Illumina Business Overview
10.7.3 Illumina Clinical Whole Exome Sequencing (WES) Introduction
10.7.4 Illumina Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.7.5 Illumina Recent Development
10.8 Thermo Fisher
10.8.1 Thermo Fisher Company Details
10.8.2 Thermo Fisher Business Overview
10.8.3 Thermo Fisher Clinical Whole Exome Sequencing (WES) Introduction
10.8.4 Thermo Fisher Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.8.5 Thermo Fisher Recent Development
10.9 Labassure
10.9.1 Labassure Company Details
10.9.2 Labassure Business Overview
10.9.3 Labassure Clinical Whole Exome Sequencing (WES) Introduction
10.9.4 Labassure Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.9.5 Labassure Recent Development
10.10 Yale Medicine
10.10.1 Yale Medicine Company Details
10.10.2 Yale Medicine Business Overview
10.10.3 Yale Medicine Clinical Whole Exome Sequencing (WES) Introduction
10.10.4 Yale Medicine Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.10.5 Yale Medicine Recent Development
10.11 Genosalut
10.11.1 Genosalut Company Details
10.11.2 Genosalut Business Overview
10.11.3 Genosalut Clinical Whole Exome Sequencing (WES) Introduction
10.11.4 Genosalut Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.11.5 Genosalut Recent Development
10.12 Caris Life Sciences
10.12.1 Caris Life Sciences Company Details
10.12.2 Caris Life Sciences Business Overview
10.12.3 Caris Life Sciences Clinical Whole Exome Sequencing (WES) Introduction
10.12.4 Caris Life Sciences Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.12.5 Caris Life Sciences Recent Development
10.13 InterGenetics
10.13.1 InterGenetics Company Details
10.13.2 InterGenetics Business Overview
10.13.3 InterGenetics Clinical Whole Exome Sequencing (WES) Introduction
10.13.4 InterGenetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.13.5 InterGenetics Recent Development
10.14 Genomics and Pathology Services (GPS)
10.14.1 Genomics and Pathology Services (GPS) Company Details
10.14.2 Genomics and Pathology Services (GPS) Business Overview
10.14.3 Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Introduction
10.14.4 Genomics and Pathology Services (GPS) Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.14.5 Genomics and Pathology Services (GPS) Recent Development
10.15 3billion
10.15.1 3billion Company Details
10.15.2 3billion Business Overview
10.15.3 3billion Clinical Whole Exome Sequencing (WES) Introduction
10.15.4 3billion Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.15.5 3billion Recent Development
10.16 Broad Genomic
10.16.1 Broad Genomic Company Details
10.16.2 Broad Genomic Business Overview
10.16.3 Broad Genomic Clinical Whole Exome Sequencing (WES) Introduction
10.16.4 Broad Genomic Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.16.5 Broad Genomic Recent Development
10.17 Roche
10.17.1 Roche Company Details
10.17.2 Roche Business Overview
10.17.3 Roche Clinical Whole Exome Sequencing (WES) Introduction
10.17.4 Roche Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.17.5 Roche Recent Development
10.18 Novogene
10.18.1 Novogene Company Details
10.18.2 Novogene Business Overview
10.18.3 Novogene Clinical Whole Exome Sequencing (WES) Introduction
10.18.4 Novogene Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.18.5 Novogene Recent Development
10.19 BGI Genomics
10.19.1 BGI Genomics Company Details
10.19.2 BGI Genomics Business Overview
10.19.3 BGI Genomics Clinical Whole Exome Sequencing (WES) Introduction
10.19.4 BGI Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.19.5 BGI Genomics Recent Development
10.20 Shanghai Jingzhou Genomics
10.20.1 Shanghai Jingzhou Genomics Company Details
10.20.2 Shanghai Jingzhou Genomics Business Overview
10.20.3 Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Introduction
10.20.4 Shanghai Jingzhou Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.20.5 Shanghai Jingzhou Genomics Recent Development
10.21 Shihe Gene Biotechnology
10.21.1 Shihe Gene Biotechnology Company Details
10.21.2 Shihe Gene Biotechnology Business Overview
10.21.3 Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Introduction
10.21.4 Shihe Gene Biotechnology Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.21.5 Shihe Gene Biotechnology Recent Development
10.22 JUNO Genomics
10.22.1 JUNO Genomics Company Details
10.22.2 JUNO Genomics Business Overview
10.22.3 JUNO Genomics Clinical Whole Exome Sequencing (WES) Introduction
10.22.4 JUNO Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
10.22.5 JUNO Genomics Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Clinical Whole Exome Sequencing (WES) Market Size India VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Clinical Whole Exome Sequencing (WES) Market Trends
Table 3. Clinical Whole Exome Sequencing (WES) Market Drivers
Table 4. Clinical Whole Exome Sequencing (WES) Market Challenges
Table 5. Clinical Whole Exome Sequencing (WES) Market Restraints
Table 6. Global Clinical Whole Exome Sequencing (WES) Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. India Clinical Whole Exome Sequencing (WES) Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Clinical Whole Exome Sequencing (WES) Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. India Clinical Whole Exome Sequencing (WES) Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Clinical Whole Exome Sequencing (WES), Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Clinical Whole Exome Sequencing (WES) Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Clinical Whole Exome Sequencing (WES) Revenue Share by Player, 2018-2023
Table 13. Global Clinical Whole Exome Sequencing (WES) Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Clinical Whole Exome Sequencing (WES) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Whole Exome Sequencing (WES) as of 2022)
Table 15. Global Key Players of Clinical Whole Exome Sequencing (WES), Headquarters and Area Served
Table 16. Global Key Players of Clinical Whole Exome Sequencing (WES), Product and Application
Table 17. Global Key Players of Clinical Whole Exome Sequencing (WES), Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Clinical Whole Exome Sequencing (WES) in India, Ranked by Revenue (2022) & (US$ Million)
Table 20. India Clinical Whole Exome Sequencing (WES) Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. India Clinical Whole Exome Sequencing (WES) Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Clinical Whole Exome Sequencing (WES) Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Clinical Whole Exome Sequencing (WES) Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Clinical Whole Exome Sequencing (WES) Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Clinical Whole Exome Sequencing (WES) Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Clinical Whole Exome Sequencing (WES) Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Clinical Whole Exome Sequencing (WES) Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Clinical Whole Exome Sequencing (WES) Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Clinical Whole Exome Sequencing (WES) Market Size by Region (2024-2033) & (US$ Million)
Table 51. CentoXome Company Details
Table 52. CentoXome Business Overview
Table 53. CentoXome Clinical Whole Exome Sequencing (WES) Product
Table 54. CentoXome Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 55. CentoXome Recent Development
Table 56. Mayo Clinic Laboratories Company Details
Table 57. Mayo Clinic Laboratories Business Overview
Table 58. Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Product
Table 59. Mayo Clinic Laboratories Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 60. Mayo Clinic Laboratories Recent Development
Table 61. Baylor Genetics Company Details
Table 62. Baylor Genetics Business Overview
Table 63. Baylor Genetics Clinical Whole Exome Sequencing (WES) Product
Table 64. Baylor Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 65. Baylor Genetics Recent Development
Table 66. Blueprint Genetics Company Details
Table 67. Blueprint Genetics Business Overview
Table 68. Blueprint Genetics Clinical Whole Exome Sequencing (WES) Product
Table 69. Blueprint Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 70. Blueprint Genetics Recent Development
Table 71. GeneDx Company Details
Table 72. GeneDx Business Overview
Table 73. GeneDx Clinical Whole Exome Sequencing (WES) Product
Table 74. GeneDx Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 75. GeneDx Recent Development
Table 76. CD Genomics Company Details
Table 77. CD Genomics Business Overview
Table 78. CD Genomics Clinical Whole Exome Sequencing (WES) Product
Table 79. CD Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 80. CD Genomics Recent Development
Table 81. Illumina Company Details
Table 82. Illumina Business Overview
Table 83. Illumina Clinical Whole Exome Sequencing (WES) Product
Table 84. Illumina Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 85. Illumina Recent Development
Table 86. Thermo Fisher Company Details
Table 87. Thermo Fisher Business Overview
Table 88. Thermo Fisher Clinical Whole Exome Sequencing (WES) Product
Table 89. Thermo Fisher Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 90. Thermo Fisher Recent Development
Table 91. Labassure Company Details
Table 92. Labassure Business Overview
Table 93. Labassure Clinical Whole Exome Sequencing (WES) Product
Table 94. Labassure Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 95. Labassure Recent Development
Table 96. Yale Medicine Company Details
Table 97. Yale Medicine Business Overview
Table 98. Yale Medicine Clinical Whole Exome Sequencing (WES) Product
Table 99. Yale Medicine Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 100. Yale Medicine Recent Development
Table 101. Genosalut Company Details
Table 102. Genosalut Business Overview
Table 103. Genosalut Clinical Whole Exome Sequencing (WES) Product
Table 104. Genosalut Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 105. Genosalut Recent Development
Table 106. Caris Life Sciences Company Details
Table 107. Caris Life Sciences Business Overview
Table 108. Caris Life Sciences Clinical Whole Exome Sequencing (WES) Product
Table 109. Caris Life Sciences Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 110. Caris Life Sciences Recent Development
Table 111. InterGenetics Company Details
Table 112. InterGenetics Business Overview
Table 113. InterGenetics Clinical Whole Exome Sequencing (WES) Product
Table 114. InterGenetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 115. InterGenetics Recent Development
Table 116. Genomics and Pathology Services (GPS) Company Details
Table 117. Genomics and Pathology Services (GPS) Business Overview
Table 118. Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Product
Table 119. Genomics and Pathology Services (GPS) Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 120. Genomics and Pathology Services (GPS) Recent Development
Table 121. 3billion Company Details
Table 122. 3billion Business Overview
Table 123. 3billion Clinical Whole Exome Sequencing (WES) Product
Table 124. 3billion Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 125. 3billion Recent Development
Table 126. Broad Genomic Company Details
Table 127. Broad Genomic Business Overview
Table 128. Broad Genomic Clinical Whole Exome Sequencing (WES) Product
Table 129. Broad Genomic Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 130. Broad Genomic Recent Development
Table 131. Roche Company Details
Table 132. Roche Business Overview
Table 133. Roche Clinical Whole Exome Sequencing (WES) Product
Table 134. Roche Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 135. Roche Recent Development
Table 136. Novogene Company Details
Table 137. Novogene Business Overview
Table 138. Novogene Clinical Whole Exome Sequencing (WES) Product
Table 139. Novogene Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 140. Novogene Recent Development
Table 141. BGI Genomics Company Details
Table 142. BGI Genomics Business Overview
Table 143. BGI Genomics Clinical Whole Exome Sequencing (WES) Product
Table 144. BGI Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 145. BGI Genomics Recent Development
Table 146. Shanghai Jingzhou Genomics Company Details
Table 147. Shanghai Jingzhou Genomics Business Overview
Table 148. Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Product
Table 149. Shanghai Jingzhou Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 150. Shanghai Jingzhou Genomics Recent Development
Table 151. Shihe Gene Biotechnology Company Details
Table 152. Shihe Gene Biotechnology Business Overview
Table 153. Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Product
Table 154. Shihe Gene Biotechnology Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 155. Shihe Gene Biotechnology Recent Development
Table 156. JUNO Genomics Company Details
Table 157. JUNO Genomics Business Overview
Table 158. JUNO Genomics Clinical Whole Exome Sequencing (WES) Product
Table 159. JUNO Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2018-2023) & (US$ Million)
Table 160. JUNO Genomics Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Clinical Whole Exome Sequencing (WES) Product Picture
Figure 2. Global Clinical Whole Exome Sequencing (WES) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Clinical Whole Exome Sequencing (WES) Market Size 2018-2033 (US$ Million)
Figure 4. India Clinical Whole Exome Sequencing (WES) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. India Clinical Whole Exome Sequencing (WES) Market Size 2018-2033 (US$ Million)
Figure 6. India Clinical Whole Exome Sequencing (WES) Market Share in Global 2018-2033
Figure 7. Clinical Whole Exome Sequencing (WES) Report Years Considered
Figure 8. Product Picture of Array-Based Exome Enrichment
Figure 9. Product Picture of Enrichment of the Exome in Solution using Biotinylated Probes
Figure 10. Global Clinical Whole Exome Sequencing (WES) Market Share by Type in 2022 & 2033
Figure 11. Global Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2033) & (US$ Million)
Figure 12. Global Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
Figure 13. India Clinical Whole Exome Sequencing (WES) Market Share by Type in 2022 & 2033
Figure 14. India Clinical Whole Exome Sequencing (WES) Market Size by Type (2018-2033) & (US$ Million)
Figure 15. India Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
Figure 16. Product Picture of Rare Genetic Disease
Figure 17. Product Picture of Genetic Testing Unsuccessful
Figure 18. Product Picture of Others
Figure 19. Global Clinical Whole Exome Sequencing (WES) Market Share by Application in 2022 & 2033
Figure 20. Global Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2033) & (US$ Million)
Figure 21. Global Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
Figure 22. India Clinical Whole Exome Sequencing (WES) Market Share by Application in 2022 & 2033
Figure 23. India Clinical Whole Exome Sequencing (WES) Market Size by Application (2018-2033) & (US$ Million)
Figure 24. India Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
Figure 25. The Top 5 and 10 Largest Companies of Clinical Whole Exome Sequencing (WES) in the World: Market Share by Clinical Whole Exome Sequencing (WES) Revenue in 2022
Figure 26. Global Clinical Whole Exome Sequencing (WES) Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 27. Global Clinical Whole Exome Sequencing (WES) Market Share by Region (2018-2033)
Figure 28. Americas Clinical Whole Exome Sequencing (WES) Market Size Growth Rate 2018-2033 (US$ Million)
Figure 29. Americas Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
Figure 30. Americas Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
Figure 31. United States Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 32. Canada Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Mexico Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Brazil Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. EMEA Clinical Whole Exome Sequencing (WES) Market Size Growth Rate 2018-2033 (US$ Million)
Figure 36. EMEA Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
Figure 37. EMEA Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
Figure 38. Europe Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 39. Middle East Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. Africa Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. China Clinical Whole Exome Sequencing (WES) Market Size Growth Rate 2018-2033 (US$ Million)
Figure 42. China Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
Figure 43. China Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
Figure 44. APAC Clinical Whole Exome Sequencing (WES) Market Size Growth Rate 2018-2033 (US$ Million)
Figure 45. APAC Clinical Whole Exome Sequencing (WES) Market Share by Type (2018-2033)
Figure 46. APAC Clinical Whole Exome Sequencing (WES) Market Share by Application (2018-2033)
Figure 47. Japan Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 48. South Korea Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. China Taiwan Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. India Clinical Whole Exome Sequencing (WES) Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. CentoXome Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 53. Mayo Clinic Laboratories Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 54. Baylor Genetics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 55. Blueprint Genetics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 56. GeneDx Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 57. CD Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 58. Illumina Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 59. Thermo Fisher Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 60. Labassure Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 61. Yale Medicine Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 62. Genosalut Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 63. Caris Life Sciences Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 64. InterGenetics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 65. Genomics and Pathology Services (GPS) Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 66. 3billion Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 67. Broad Genomic Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 68. Roche Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 69. Novogene Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 70. BGI Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 71. Shanghai Jingzhou Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 72. Shihe Gene Biotechnology Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 73. JUNO Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries